Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.00
+0.20 (3.45%)
May 14, 2025, 4:38 PM CET
Hyloris Pharmaceuticals Revenue
In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M EUR with 159.64% growth. Hyloris Pharmaceuticals had revenue of 5.12M in the half year ending December 31, 2024, with 278.14% growth.
Revenue
9.76M
Revenue Growth
+159.64%
P/S Ratio
17.39
Revenue / Employee
199.18K
Employees
49
Market Cap
169.68M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.45B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 498.16M |
| Nyxoah | 4.52M |
| Onward Medical | 1.74M |
| Sequana Medical NV | 105.50K |